More articles from Research Letter

You have access
Impact of Axial Spondyloarthritis on Quality of Life: Results From the European Map of Axial Spondyloarthritis (EMAS) Study in France
Joanna Kedra, Pascal Claudepierre, René-Marc Flipo, Marco Garrido-Cumbrera, Françoise Alliot-Launois, Emilie Desfleurs, Laurent Grange and Laure Gossec

The Journal of Rheumatology October 1 2022, 49 (10) 1176-1178; DOI: https://doi.org/10.3899/jrheum.210864
You have access
Immunogenicity of COVID-19 Vaccination in Patients With Axial Spondyloarthritis: A Monocentric Prospective Belgian Cohort Study
Tracy Vandergraesen, Leila Mekkaoui, Hafid Dahma, Muhammad Soyfoo and Laure Tant

The Journal of Rheumatology September 1 2022, 49 (9) 1072-1074; DOI: https://doi.org/10.3899/jrheum.211313
You have access
Active Disease in Psoriatic Arthritis: An Assessment of Spondyloarthritis International Society Health Index (ASAS-HI)–based Analysis
Rubén Queiro, Isla Morante and Ignacio Braña

The Journal of Rheumatology August 1 2022, 49 (8) 961-963; DOI: https://doi.org/10.3899/jrheum.210887
You have access
Impaired Humoral Immunogenicity of SARS-CoV-2 Vaccination in Patients With Rheumatoid Arthritis
Camille Le Moine, Muhammad Shahnawaz Soyfoo, Leila Mekkaoui, Hafid Dahma and Laure Tant

The Journal of Rheumatology July 1 2022, 49 (7) 855-858; DOI: https://doi.org/10.3899/jrheum.211270
You have access
Tumor Necrosis Factor-α Inhibition Before and After Rituximab Treatment in Juvenile Idiopathic Arthritis: What Shall We Expect? A Pilot Study
Achille Marino, Francesco Orsini, Francesca Pregnolato and Rolando Cimaz

The Journal of Rheumatology June 1 2022, 49 (6) 654-656; DOI: https://doi.org/10.3899/jrheum.211039
You have access
Fibroblast Growth Factor 23 Levels in Pulmonary Involvement Associated With Systemic Sclerosis: A Proof-of-concept Study
Luis M. Amezcua-Guerra, Mauricio Mora-Ramirez, Gonzalo Vancini, Valentín Jimenez-Rojas and Ricardo Márquez-Velasco

The Journal of Rheumatology May 1 2022, 49 (5) 542-544; DOI: https://doi.org/10.3899/jrheum.211156
You have access
Evaluation of Disease Burden by (Separate) Patient-reported, Clinical, and Laboratory Factor Scores in Patients With Established Rheumatoid Arthritis: A Factor Analysis Replication
Sofia Pazmino, Anikó Lovik, René Westhovens and Patrick Verschueren on behalf of TapERA Study Group

The Journal of Rheumatology April 1 2022, 49 (4) 436-437; DOI: https://doi.org/10.3899/jrheum.210871
You have access
Safety Profile and Low Risk of Disease Relapse After BNT162b2 mRNA SARS-CoV-2 Vaccination in Patients With Rare Rheumatic Diseases
Marco Fornaro, Vincenzo Venerito, Florenzo Iannone and Fabio Cacciapaglia

The Journal of Rheumatology March 1 2022, 49 (3) 334-335; DOI: https://doi.org/10.3899/jrheum.210863
You have access
Improving COVID-19 Vaccine Coverage in Patients With Autoimmune and Inflammatory Diseases
Tiphaine Goulenok, Chrystelle Francois, Céline Mendes, Fatima Farhi, Jean-Francois Alexandra, Diane Rouzaud, Thomas Papo and Karim Sacre

The Journal of Rheumatology January 1 2022, 49 (1) 118-119; DOI: https://doi.org/10.3899/jrheum.210534
You have access
Abatacept as Adjunctive Therapy in Refractory Polymyalgia Rheumatica
Eric Toussirot, Martin Michaud, Daniel Wendling and Valérie Devauchelle

The Journal of Rheumatology December 1 2021, 48 (12) 1888-1889; DOI: https://doi.org/10.3899/jrheum.210455

Main menu

User menu

Search

More articles from Research Letter

Pages

Content

Resources

Subscribers

More